ATE284900T1 - Spezifische antikörper für dendritische zellen - Google Patents

Spezifische antikörper für dendritische zellen

Info

Publication number
ATE284900T1
ATE284900T1 AT97945110T AT97945110T ATE284900T1 AT E284900 T1 ATE284900 T1 AT E284900T1 AT 97945110 T AT97945110 T AT 97945110T AT 97945110 T AT97945110 T AT 97945110T AT E284900 T1 ATE284900 T1 AT E284900T1
Authority
AT
Austria
Prior art keywords
dendritic cells
specific antibodies
antigen
antibody
antibodies
Prior art date
Application number
AT97945110T
Other languages
English (en)
Inventor
Derek Nigel John Hart
Original Assignee
Canterbury Health Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canterbury Health Ltd filed Critical Canterbury Health Ltd
Application granted granted Critical
Publication of ATE284900T1 publication Critical patent/ATE284900T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT97945110T 1996-10-09 1997-10-09 Spezifische antikörper für dendritische zellen ATE284900T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ29953796 1996-10-09
PCT/NZ1997/000134 WO1998015579A1 (en) 1996-10-09 1997-10-09 Dendritic cell-specific antibodies

Publications (1)

Publication Number Publication Date
ATE284900T1 true ATE284900T1 (de) 2005-01-15

Family

ID=19925969

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97945110T ATE284900T1 (de) 1996-10-09 1997-10-09 Spezifische antikörper für dendritische zellen

Country Status (7)

Country Link
US (1) US6479247B1 (de)
EP (1) EP0956304B1 (de)
JP (2) JP2001502670A (de)
AT (1) ATE284900T1 (de)
AU (1) AU744637B2 (de)
DE (1) DE69731977T2 (de)
WO (1) WO1998015579A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020187131A1 (en) * 1995-01-31 2002-12-12 Daniel Hawiger Enhanced antigen delivery and modulation of the immune response therefrom
US20040258688A1 (en) * 1995-01-31 2004-12-23 Daniel Hawiger Enhanced antigen delivery and modulation of the immune response therefrom
WO1999006811A2 (en) * 1997-08-01 1999-02-11 Derek Nigel John Hart Method for counting dendritic cells
DE69934792D1 (de) * 1998-05-11 2007-02-22 Rieber E P Antikörper gegen dendritische zellen und menschliche dendritische zellpopulationen und deren verwendungen
US6495333B1 (en) 1998-09-22 2002-12-17 Becton Dickinson And Company Flow cytometric, whole blood dendritic cell immune function assay
US7351546B2 (en) 1998-09-22 2008-04-01 Becton, Dickinson And Company Flow cytometric, whole blood dendritic cell immune function assay
US7030228B1 (en) 1999-11-15 2006-04-18 Miltenyi Biotec Gmbh Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
EP1237929A4 (de) * 1999-12-03 2004-04-28 Order Sisters Of Mercy Queensl Spezifische antikörper für dendritenzellen
US7560534B2 (en) 2000-05-08 2009-07-14 Celldex Research Corporation Molecular conjugates comprising human monoclonal antibodies to dendritic cells
CA2408594A1 (en) * 2000-05-08 2001-11-15 Medarex, Inc. Human monoclonal antibodies to dendritic cells
US9259459B2 (en) * 2003-01-31 2016-02-16 Celldex Therapeutics Inc. Antibody vaccine conjugates and uses therefor
US9243064B2 (en) * 2003-01-31 2016-01-26 Celldex Therapeutics Inc. Antibody vaccine conjugates and uses therefor
CN101466828B (zh) * 2006-04-13 2011-12-21 株式会社医学生物学研究所 融合伴侣细胞
NZ585556A (en) 2007-11-07 2012-07-27 Celldex Therapeutics Inc Antibodies that bind human dendritic and epithelial cell 205 (dec-205)
ES2738700T3 (es) 2009-02-13 2020-01-24 Immunomedics Inc Inmunoconjugados con un enlace escindible intracelularmente
WO2011034660A1 (en) 2009-09-16 2011-03-24 Immunomedics, Inc. Class i anti-cea antibodies and uses thereof
CA2782194C (en) 2009-12-02 2018-01-16 Immunomedics, Inc. Combination of radiolabelled antibodies (rait) and antibody-drug conjugates (adc) for treatment of pancreatic cancer
WO2012151199A1 (en) 2011-05-02 2012-11-08 Immunomedics, Inc. Ultrafiltration concentration of allotype selected antibodies for small-volume administration
US9119462B2 (en) 2011-07-23 2015-09-01 Braun Gmbh Oral cleaning implement having a plastic staple comprising a cavity
WO2014028560A2 (en) 2012-08-14 2014-02-20 Ibc Pharmaceuticals, Inc. T-cell redirecting bispecific antibodies for treatment of disease
HRP20220399T1 (hr) 2012-12-13 2022-05-13 Immunomedics, Inc. Režim doziranja imunokonjugata protutijela i sn-38 za poboljšanu učinkovitost i smanjenu toksičnost
WO2015126548A1 (en) 2014-02-21 2015-08-27 Ibc Pharmaceuticals, Inc. Disease therapy by inducing immune response to trop-2 expressing cells
CA2935748A1 (en) 2014-02-25 2015-09-03 Immunomedics, Inc. Humanized rfb4 anti-cd22 antibody
WO2015200260A1 (en) 2014-06-24 2015-12-30 Immunomedics, Inc. Anti-histone therapy for vascular necrosis in severe glomerulonephritis
CA2961774C (en) 2014-10-07 2023-05-23 Immunomedics, Inc. Neoadjuvant use of antibody-drug conjugates
CN104610452B (zh) * 2015-01-27 2018-11-20 中国科学技术大学先进技术研究院 抗人cd83单克隆抗体及其制备、鉴定和应用
CA2981543A1 (en) 2015-04-22 2016-10-27 Immunomedics, Inc. Isolation, detection, diagnosis and/or characterization of circulating trop-2-positive cancer cells
CN114796501A (zh) 2015-06-25 2022-07-29 免疫医疗公司 抗体与治疗剂的组合治疗癌症的方法
EP3316885B1 (de) 2015-07-01 2021-06-23 Immunomedics, Inc. Antikörper-sn-38-immunkonjugate mit einem cl2a-linker
EP4342497A1 (de) 2021-05-10 2024-03-27 Kawasaki Institute of Industrial Promotion Antikörper mit reduzierter bindungsaffinität für antigen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
US5876917A (en) * 1993-11-04 1999-03-02 Canterbury Health Limited Dendritic cell-specific antibodies and method for their preparation
WO1995015340A1 (en) * 1993-12-03 1995-06-08 The Board Of Trustees Of Leland Stanford Junior University Monoclonal antibodies to antigens expressed by human dendritic cells

Also Published As

Publication number Publication date
US6479247B1 (en) 2002-11-12
JP2008148707A (ja) 2008-07-03
US20020155510A1 (en) 2002-10-24
AU4639397A (en) 1998-05-05
EP0956304A4 (de) 2000-01-26
DE69731977D1 (de) 2005-01-20
EP0956304B1 (de) 2004-12-15
WO1998015579A1 (en) 1998-04-16
EP0956304A1 (de) 1999-11-17
AU744637B2 (en) 2002-02-28
DE69731977T2 (de) 2005-12-08
JP2001502670A (ja) 2001-02-27

Similar Documents

Publication Publication Date Title
ATE284900T1 (de) Spezifische antikörper für dendritische zellen
SE9502196D0 (sv) Ultrasensitive immunoassays
DK0914155T3 (da) Monoklonale antistoffer, der er spepcifikke for det ekstracellulære domæne af prostataspecifikt membran-antigen
ES2171676T3 (es) Inmunoensayos por quimioluminiscencia para la deteccion de anticuerpos.
AR008919A1 (es) Anticuerpos anti-cd11a humanizados.
DE69026615D1 (de) Igg3-antikörper mit verkürzter hinge-region und einem komplementaktivierungstest
DE59508474D1 (de) RHEUMAFAKTOR-ENTSTÖRUNG MIT ANTI-Fd-ANTIKÖRPERN
ATE217086T1 (de) Herstellung von photoprotein konjugaten und verfahren zu ihrer verwendung
EP0902286A3 (de) Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay
ES2141348T3 (es) Metodo de deteccion de la presencia de una especie de mycobacterium, kit y anticuerpos utilizados en este metodo.
BR0011449A (pt) Método para detectar sìfilis usando antìgenos sintéticos
ATE198512T1 (de) Transfizierte zelllinien die autoantigene exprimieren und ihre verwendung in immunotests zur erkennung von autoimmunkrankheiten
EP0824104A3 (de) Immunotestverfahren
CA2213083A1 (en) Detection of antibody production
AU4086397A (en) Monoclonal antibodies specific for prostate specific antigen and methods of detecting prostate specific antigen
ES2187639T3 (es) Analisis de fijacion competitiva para antigenos plaquetarios.
Hajdu The immunohistochemical detection of J chain in lymphoid cells in tissue sections: the necessity of trypsin digestion
CO5300499A1 (es) Ensayo de inmunoabsorbente ligado a enzima de inhibicion (elisa) para deteccion y cuantificacion de anticuerpos en muestras biologicas
KR850008620A (ko) Atl 바이러스 항체의 측정방법 및 시약
MX9704717A (es) Antigeno, anticuerpos y ensayo de diagnostico para la enfermedad de alzheimer.
WO1990008956A1 (fr) Detection d'activateur de facteur tissulaire humain
ATE263784T1 (de) Anti-megakaryozyten monoklonaler antikörper 97a6
AU2868489A (en) Assays for incipient diabetes, monoclonal antibodies used therein and kits for use therefor
SE9900875D0 (sv) Antinuclear antibody assay utilizing stress-treated cells or cell extracts
HU9701386D0 (en) Immunoassay method

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties